2-Oxoacids regulate kynurenic acid production in the rat brain: Studies in vitro and in vivo

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 643-651

  Hodgkins, Paul S ^b   Wu, Hui Qiu ^b   Zielke, H Ronald ^a   Schwarcz, Robert ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Excitotoxicity; Hypoglycemia; Kynurenines; Neuroprotection; NMDA

Indexed keywords

2 OXOACID; 2 OXOGLUTARIC ACID; 2 OXOISOCAPROIC ACID; 2 OXOISOVALERIC ACID; 2 OXOMETHYLBUTYRIC ACID; AMINOADIPIC ACID; AMINOOXYACETIC ACID; DICHLOROVINYLCYSTEINE; EXCITATORY AMINO ACID RECEPTOR; KYNURENIC ACID; KYNURENINE; KYNURENINE AMINOTRANSFERASE; OXALOACETIC ACID; PYRUVIC ACID; QUISQUALIC ACID; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSAMINATION;

2-AMINOADIPIC ACID; ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; CORPUS STRIATUM; EXCITATORY AMINO ACID AGONISTS; GLUCOSE; HIPPOCAMPUS; HYPOGLYCEMIA; KYNURENIC ACID; KYNURENINE; MALE; MICRODIALYSIS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PYRUVIC ACID; QUISQUALIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TRANSAMINASES; VERATRIDINE;

EID: 0032937178     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720643.x     Document Type: Article

References (56)

1. Beal M. F., Matson W. R., Storey E., Milbury P., Ryan E. A., Ogawa T., and Bird E. D. (1992) Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J. Neurol. Sci. 108, 80-87.
2. Brand K. A. and Hermfisse U. (1997) Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388-395.
3. Buchli R., Alberati-Giani D., Malherbe P., Köhler C., Broger C., and Cesura A. M. (1995) Cloning and functional expression of a soluble form of kynurenine/α-aminoadipate aminotransferase from rat kidney. J. Biol. Chem. 270, 29330-29335.
4. Ceresoli-Borroni G., Guidetti P., and Schwarcz R. (1999) Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. J. Neural Transm. (in press).
5. Cohen G., Farooqui R., and Kesler N. (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 84, 4890-4894.
6. Conn A. R., Fell D. I., and Steele R. D. (1983) Characterization of a-keto acid transport across blood-brain barrier in rats. Am. J. Physiol. 245, E253-E260.
7. Desagher S., Glowinski J., and Prémont J. (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17, 9060-9067.
8. Dijkstra U., Gabreëls F., Joosten E., Wevers R., Lamers K., Doesburg W., and Renier W. (1984) Friedreich's ataxia: intravenous pyruvate load to demonstrate a defect in pyruvate metabolism. Neurology 34, 1493-1497.
9. Fitzpatrick S. M., Cooper A. J. L., and Duffy T. E. (1983) Use of β-methylene-D,L-aspartate to assess the role of aspartate amino-transferase in cerebral oxidative metabolism. J. Neurochem. 41, 1370-1383.
10. Foster A. C., Vezzani A., French E. D., and Schwarcz R. (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rat by the related brain metabolite quinolinic acid. Neurosci. Lett. 48, 273-278.
11. Fukui S., Schwarcz R., Rapoport S. I., Takada Y., and Smith Q. R. (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007-2017.
12. Giandomenico A. R., Cereniglia G. E., Biaglow J. E., Stevens C. W., and Koch C. J. (1997) The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic. Biol. Med. 23, 426-434.
13. Gill R. and Woodruff G. N. (1990) The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur. J. Phamacol. 176, 143-149.
14. Gramsbergen J. B. P., Hodgkins P. S., Rassoulpour A., Turski W. A., Guidetti P., and Schwarcz R. (1997) Brain-specific modulation of kynurenic acid synthesis in the rat. J. Neurochem. 69, 290-298.
15. Guidetti P. and Schwarcz R. (1997) 3-Hydroxykynurenine augments the neurotoxicity of quinolinate in the rat striatum. Soc. Neurosci. Abstr. 23, 2315.
16. 3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway. J. Neurochem. 65, 2621-2632.
17. Guidetti P., Okuno E., and Schwarcz R. (1997) Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50, 457-465.
18. Harada I., Noguchi T., and Kido R. (1978) Purification and characterization of aromatic-amino-acid-glyoxylate aminotransferase from monkey and rat liver. Hoppe-Seylers Z. Physiol. Chem. 359, 481-488.
19. Heyes M. P. (1993) Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid. Biochem. Soc. Trans. 21, 83-89.
20. Hodgkins P. S. and Schwarcz R. (1997) Up-regulation of kynurenic acid production in rat brain slices by endogenous 2-oxoacids. Soc. Neurosci. Abstr. 23, 2315.
21. Hodgkins P. S. and Schwarcz R. (1998a) Metabolic control of kynurenic acid formation in the rat brain. Dev. Neurosci. 20, 408-416.
22. Hodgkins P. S. and Schwarcz R. (1998b) Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate. Eur. J. Neurosci. 10, 1986-1994.
23. Izumi Y., Benz A. M., Zorumski C. F., and Olney J. W. (1994) Effects of lactate and pyruvate on glucose deprivation in rat hippocampal slices. Neuroreport 5, 617-620.
24. Izumi Y., Benz A. M., Katsuki H., and Zorumski C. F. (1997) Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation. J. Neurosci. 17, 9448-9457.
25. Kato Y., Asano Y., and Cooper A. J. L. (1996) Inactivation of brain and kidney aspartate aminotransferases by S-(1,2-dichlorovinyl)-L-cysteine and by S-(1,1,2,2-tetrafluoroethyl)-L-cysteine. Dev. Neurosci. 18, 505-514.
26. Kuriyama K., Roberts E., and Rubenstein M. K. (1966) Elevation of γ-amino-butyric acid in brain with amino-oxyacetic acid and susceptibility to convulsive seizures in mice: a quantitative reevaluation. Biochem. Pharmacol. 15, 221-236.
27. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
28. Mitch W. E., Abras E., and Walser M. (1982) Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int. 22, 48-53.
29. Moroni F., Russi P., Lombardi G., Beni M., and Carlà V. (1988) Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51, 177-180.
30. Mosca M., Cozzi L., Breton J., Speciale C., Okuno E., Schwarcz R., and Benatti L. (1994) Molecular cloning of rat kynurenine aminotransferase: identity with glutamine transaminase K. FEBS Lett. 353, 21-24.
31. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
32. Noguchi T., Minatogawa Y., Okuno E., Nakatani M., and Kido R. (1975) Purification and characterization of kynurenine-2-oxoglutarate aminotransferase from the liver, brain and small intestine of rats. Biochem. J. 151, 399-406.
33. O'Donnell-Tormey J., Nathan C. F., Lanks K., DeBoer C. J., and de la Harpe J. (1987) Secretion of pyruvate - an antioxidant defense of mammalian cells. J. Exp. Med. 165, 500-514.
34. Okuda S., Nishiyama N., Saito H., and Katsuki H. (1996) Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl. Acad. Sci. USA 93, 12553-12558.
35. Okuda S., Nishiyama N., Saito H., and Katsuki H. (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 70, 299-307.
36. Okuno E., Schmidt W., Parks D. A., Nakamura M., and Schwarcz R. (1991) Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J. Neurochem. 57, 533-540.
37. Oldendorf W. H. (1973) Carrier-mediated blood-brain barrier transport of short chain monocarboxylic organic acids. Am. J. Physiol. 224, 1450-1453.
38. Parsons C. G., Danysz W., Quack G., Hartmann S., Lorenz B., Wollenburg C., Baran L., Przegalinski E., Kostowski W., Krzascik P., Chizh B., and Headley P. M. (1997) Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. J. Pharmacol. Exp. Ther. 283, 1264-1275.
39. Pearson S. J. and Reynolds G. P. (1991) Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 565, 436-440.
40. Poeggeler B., Rassoulpour A., Guidetti P., Wu H.-Q., and Schwarcz R. (1998) Dopaminergic control of kynurenate levels and NMDA toxicity in the developing rat striatum. Dev. Neurosci. 20, 146-153.
41. Rist R. J., Romero I. A., Chan M. W. K., and Abbott N. J. (1996) Effects of energy deprivation induced by fluorocitrate in immortalized rat brain microvessel endothelial cells. Brain Res. 730, 87-94.
42. Saito K., Nowak T. S. Jr., Suyama K., Quearry B. J., Saito M., Crawley J. S., Markey S. P., and Heyes M. P. (1993) Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus sys-temic immune activation. J. Neurochem. 61, 2061-2070.
43. Schwarcz R., Whetsell W. O. Jr., and Mangano R. M. (1983) Quinolinic acid: an endogenous metabolite that causes axon-sparing lesions in rat brain. Science 219, 316-318.
44. Schwarcz R., Foster A. C., French E. D., Whetsell W. O. Jr., and Köhler C. (1984) Excitotoxic models for neurodegenerative disorders. Life Sci. 35, 19-32.
45. Speciale C. and Schwarcz R. (1990) Uptake of kynurenine into rat brain slices. J. Neurochem. 54, 156-163.
46. +-independent transporter of neutral amino acids in astrocytes. J. Neurosci. 9, 2066-2072.
47. Stanko R. T., Reynolds H. R., Hoyson R., Janosky J. E., and Wolf R. (1994) Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am. J. Clin. Nutr. 59, 423-427.
48. Steele R. D. (1986) Blood-brain barrier transport of the α-keto acid analogs of amino acids. Fed. Proc. 45, 2060-2064.
49. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 45, 309-379.
50. Tsacopoulos H. and Magistretti P. J. (1996) Metabolic coupling between glia and neurons. J. Neurosci. 16, 877-885.
51. Turski W. A., Nakamura M., Todd W. P., Carpenter B. K., Whetsell W. O. Jr., and Schwarcz R. (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454, 164-169.
52. Turski W. A., Gramsbergen J. B. P., Traitler H., and Schwarcz R. (1989) Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J. Neurochem. 52, 1629-1636.
53. Walser M., Coulter A. W., Dighe A. W., and Crantz F. R. (1973) The effect of keto-analogues of essential amino acids in severe chronic uremia. J. Clin. Invest. 52, 678-690.
54. Wu H.-Q. and Schwarcz R. (1996) Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain. Brain Res. Bull. 39, 155-162.
55. Wu H.-Q., Baran H., Ungerstedt U., and Schwarcz R. (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4, 1264-1270.
56. Wu H.-Q., Ungerstedt U., and Schwarcz R. (1995) L-α-Aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats. Eur. J. Pharmacol. 281, 55-61.